- Investigator
- Renee F Modica
- Status
- Accepting Candidates
Renee F Modica, MD, MSED : Research
Pediatric Rheumatologist (Child Joint Disease Specialist)
Research at a glance
Top areas of exploration
- Antibodies, Monoclonal, Humanized , 3 publications
- Lupus Erythematosus, Systemic , 3 publications
- Rituximab , 3 publications
- Immunosuppressive Agents , 3 publications
Research activity
Active clinical trials
- Investigator
- Renee F Modica
- Status
- Accepting Candidates
My publications
Filter publications
26 publications
2026
Emapalumab use in malignancy-associated hemophagocytic lymphohistiocytosis in the United States: the REAL-HLH study.
Blood advances
PubMed • Publisher's site2025
Emapalumab treatment in rheumatologic disease-associated hemophagocytic lymphohistiocytosis: a plain language summary.
Immunotherapy
PubMed • Publisher's site2025
Emapalumab Treatment in Patients With Rheumatologic Disease-Associated Hemophagocytic Lymphohistiocytosis in the United States: A Retrospective Medical Chart Review Study.
Arthritis & rheumatology (Hoboken, N.J.)
PubMed • Publisher's site2023
Does kidney biopsy in pediatric lupus patients "complement" the management and outcomes of silent lupus nephritis? Lessons learned from a pediatric cohort.
Pediatric nephrology (Berlin, Germany)
PubMed • Publisher's site2023
Bortezomib is efficacious in the treatment of severe childhood-onset neuropsychiatric systemic lupus erythematosus with psychosis: a case series and mini-review of B-cell immunomodulation in antibody-mediated diseases
Clinical Rheumatology
Publisher's site